Overview

Clinical Trial for Prostate Cancer

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase III trial using an injectable for treatment of prostate cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Oakwood Laboratories, LLC
Treatments:
Leuprolide